These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23707151)

  • 21. Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma: the dummy run.
    Davis JB; Reiner B; Dusserre A; Giraud JY; Bolla M;
    Radiother Oncol; 2002 Jul; 64(1):65-73. PubMed ID: 12208577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do results of the EORTC dummy run predict quality of radiotherapy delivered within multicentre clinical trials?
    Fairchild A; Collette L; Hurkmans CW; Baumert B; Weber DC; Gulyban A; Poortmans P
    Eur J Cancer; 2012 Nov; 48(17):3232-9. PubMed ID: 22766515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run.
    Hurkmans CW; Borger JH; Rutgers EJ; van Tienhoven G; ;
    Radiother Oncol; 2003 Sep; 68(3):233-40. PubMed ID: 13129630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV/p16 negative squamous cell carcinoma of the head and neck: Results of the benchmark case procedure.
    Christiaens M; Collette S; Overgaard J; Gregoire V; Kazmierska J; Castadot P; Giralt J; Grant W; Tomsej M; Bar-Deroma R; Monti AF; Hurkmans CW; Weber DC
    Radiother Oncol; 2017 Jun; 123(3):424-430. PubMed ID: 28478912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality assurance of the EORTC radiotherapy trial 22931 for head and neck carcinomas: the dummy run.
    Valley JF; Bernier J; Tercier PA; Fogliata-Cozzi A; Rosset A; Garavaglia G; Mirimanoff RO
    Radiother Oncol; 1998 Apr; 47(1):37-44. PubMed ID: 9632290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group.
    Nielsen MH; Berg M; Pedersen AN; Andersen K; Glavicic V; Jakobsen EH; Jensen I; Josipovic M; Lorenzen EL; Nielsen HM; Stenbygaard L; Thomsen MS; Vallentin S; Zimmermann S; Offersen BV;
    Acta Oncol; 2013 May; 52(4):703-10. PubMed ID: 23421926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality assurance in the EORTC phase III randomised 'boost vs. no boost' trial for breast conserving therapy: comparison of the results of two individual case reviews performed early and late during the accrual period.
    Poortmans PM; Ataman F; Davis JB; Bartelink H; Horiot JC; Pierart M; Collette L; Van Tienhoven G
    Radiother Oncol; 2005 Sep; 76(3):278-84. PubMed ID: 15919127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer.
    Weber DC; Hurkmans CW; Melidis C; Budach W; Langendijk JH; Peters LJ; Grégoire V; Maingon P; Combescure C
    Radiother Oncol; 2014 Jun; 111(3):393-9. PubMed ID: 24861631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I--III breast cancer(1).
    Poortmans PM; Venselaar JL; Struikmans H; Hurkmans CW; Davis JB; Huyskens D; van Tienhoven G; Vlaun V; Lagendijk JJ; Mijnheer BJ; De Winter KA; Van der Hulst MH; Van den Bogaert WF
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1399-408. PubMed ID: 11286848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of radiotherapy reporting in randomized controlled trials of prostate cancer.
    Soon YY; Chen D; Tan TH; Tey J
    Radiat Oncol; 2018 Jun; 13(1):108. PubMed ID: 29880015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benchmarking dosimetric quality assessment of prostate intensity-modulated radiotherapy.
    Senthi S; Gill SS; Haworth A; Kron T; Cramb J; Rolfo A; Thomas J; Duchesne GM; Hamilton CH; Joon DL; Bowden P; Foroudi F
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):998-1005. PubMed ID: 21310548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality assurance in preoperative radiotherapy of rectal cancer: evaluation of a pre-trial dummy-run.
    Widder J; Sedlmayer F; Stanek C; Pötter R
    Radiother Oncol; 2000 Sep; 56(3):341-7. PubMed ID: 10974384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality assurance of the EORTC Trial 22881/10882: boost versus no boost in breast conserving therapy. An overview.
    van Tienhoven G; Mijnheer BJ; Bartelink H; González DG
    Strahlenther Onkol; 1997 Apr; 173(4):201-7. PubMed ID: 9111608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and physical quality assurance for intensity modulated radiotherapy of prostate cancer.
    Boehmer D; Bohsung J; Eichwurzel I; Moys A; Budach V
    Radiother Oncol; 2004 Jun; 71(3):319-25. PubMed ID: 15172148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality assurance of the EORTC trial 22881/10882: "assessment of the role of the booster dose in breast conserving therapy": the Dummy Run. EORTC Radiotherapy Cooperative Group.
    van Tienhoven G; van Bree NA; Mijnheer BJ; Bartelink H
    Radiother Oncol; 1991 Dec; 22(4):290-8. PubMed ID: 1792323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimising the dosimetric quality and efficiency of post-prostatectomy radiotherapy: a planning study comparing the performance of volumetric-modulated arc therapy (VMAT) with an optimised seven-field intensity-modulated radiotherapy (IMRT) technique.
    Nguyen BT; Hornby C; Kron T; Cramb J; Rolfo A; Pham D; Haworth A; Tai KH; Foroudi F
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):211-9. PubMed ID: 22498196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EORTC guidelines for writing protocols for clinical trials of radiotherapy.
    Bolla M; Bartelink H; Garavaglia G; Gonzalez D; Horiot JC; Johansson KA; van Tienhoven G; Vantongelen K; van Glabbeke M
    Radiother Oncol; 1995 Jul; 36(1):1-8. PubMed ID: 8525020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience-based quality control of clinical intensity-modulated radiotherapy planning.
    Moore KL; Brame RS; Low DA; Mutic S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):545-51. PubMed ID: 21277097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transperitoneal laparoscopic prostatectomy does not increase small bowel within the target volume for postoperative radiotherapy.
    Finelli A; Punnen S; Rosewall T; Catton C; Fleshner N; Jewett M; Trachtenberg J; Menard C
    J Urol; 2009 Nov; 182(5):2280-4. PubMed ID: 19762047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.